On March 5, 2026, Tether Investments announced a strategic funding round in Eight Sleep, propelling the New York-based sleep technology company to a valuation of $1.5 billion. Eight Sleep currently operates in 34 countries, recently achieved positive free cash flow, and has launched three new products.
From Sleep Optimization to Predictive Health
Eight Sleep is leveraging the fresh capital to evolve from a sleep optimization hardware maker into a predictive artificial intelligence health platform. The company is developing an AI agent trained on over one billion hours of sleep data, designed to anticipate and mitigate sleep disruptions before they occur. In parallel, Eight Sleep has initiated FDA filings for sleep apnea detection and mitigation, aiming to transform its hardware into a regulated medical device.
Tether's Bet on AI-Powered Personal Health
“We believe advanced personalized AI is the perfect pathway to understand and expand human potential,” said Paolo Ardoino, CEO of Tether. “Eight Sleep has the potential to define the future of health tech by building intelligence that learns, scales, and evolves directly with humankind, turning advanced AI into practical, everyday insights and enhancements about core human biology.” The investment marks Tether's latest foray beyond crypto into tangible technology, following its involvement in Lugano's Plan ₿ initiative.
Market Implications
Eight Sleep's smart mattress has long been a favorite among Silicon Valley elites. With Tether's strategic backing, the company is expected to accelerate global expansion and regulatory milestones. Analysts view the deal as a signal that crypto-native capital is increasingly flowing into regulated health tech, potentially paving the way for more cross-industry partnerships.